About Businesses Partnering News Contact CONTACT Let’s talk. Keyboard shortcuts Map data ©2021 Terms of Use Report a map error Contact us Name * First Name Last Name Email Address * Phone * Please begin with country code if outside the USA or Canada. Reason of Inquiry * DFB Phyton Biotech NanOlogy Commercial Products Partnering Other Message * Please do not include confidential or sensitive information in your message. ➤ LOCATION 3909 Hulen Street Fort Worth, Texas 76107 OFFICE HOURS Monday - Friday 8AM - 5PM ☎ CONTACT dfbpharma@dfb.com (817)900-4050 DFB PHARMACEUTICALS home | about | news | contact | legal (817) 900-4050 | dfbpharma@dfb.com 3909 Hulen Street, Fort Worth, Texas 76107 Copyright 2017-20 DFB Pharmaceuticals By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively. OK

About Businesses Partnering News Contact We couldn't find the page you were looking for. This is either because: There is an error in the URL entered into your web browser. Please check the URL and try again. The page you are looking for has been moved or deleted. You can return to our homepage by clicking here, or you can try searching for the content you are seeking by clicking here. DFB PHARMACEUTICALS home | about | news | contact | legal (817) 900-4050 | dfbpharma@dfb.com 3909 Hulen Street, Fort Worth, Texas 76107 Copyright 2017-20 DFB Pharmaceuticals By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively. OK

About Businesses Partnering News Contact NANOLOGY Big ideas in action. Clinical Development of a Large Surface Area Microparticle Drug Platform to Treat Cancer DFB formed NanOlogy™ in 2015 to advance intratumoral drug therapy increase the effectiveness of cancer treatment while minimizing systemic side effects. NanOlogy, LLC is a company formed in collaboration with CritiTech, Inc. of Lawrence, KS, and US Biotest, Inc. of San Luis Obispo, CA, to finance and develop a breakthrough supercritical precipitation (SCP) technology platform aimed at tumor-directed drug therapy to improve cancer treatment across the disease spectrum. VISIT THE NANOLOGY WEBSITE > SEE OUR CLINICAL DRUG DEVELOPMENT PIPELINE > DFB PHARMACEUTICALS home | about | news | contact | legal (817) 900-4050 | dfbpharma@dfb.com 3909 Hulen Street, Fort Worth, Texas 76107 Copyright 2017-20 DFB Pharmaceuticals By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively. OK